User profiles for "author:G Monteleone"
Giovanni MonteleoneProfessore Ordinario di Gastroenterologia Università di Roma Tor Vergata Verified email at med.uniroma2.it Cited by 30112 |
Immunity, inflammation, and allergy in the gut
TT MacDonald, G Monteleone - Science, 2005 - science.org
The gut immune system has the challenge of responding to pathogens while remaining
relatively unresponsive to food antigens and the commensal microflora. In the developed …
relatively unresponsive to food antigens and the commensal microflora. In the developed …
The gut‐skin axis in health and disease: a paradigm with therapeutic implications
CA O'Neill, G Monteleone, JT McLaughlin, R Paus - Bioessays, 2016 - Wiley Online Library
As crucial interface organs gut and skin have much in common. Therefore it is unsurprising
that several gut pathologies have skin co‐morbidities. Nevertheless, the reason for this …
that several gut pathologies have skin co‐morbidities. Nevertheless, the reason for this …
Regulation of homeostasis and inflammation in the intestine
The gastrointestinal tract is the largest immune interface with the environment. Exposure to
large numbers of dietary and microbial antigens requires complex and highly regulated …
large numbers of dietary and microbial antigens requires complex and highly regulated …
Cutting edge: TGF-β induces a regulatory phenotype in CD4+ CD25− T cells through Foxp3 induction and down-regulation of Smad7
Abstract CD4+ CD25+ regulatory cells are a subpopulation of T lymphocytes of thymic
origin. However, recent data suggest an alternative commitment of regulatory T cells in the …
origin. However, recent data suggest an alternative commitment of regulatory T cells in the …
[HTML][HTML] Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
Colorectal cancers (CRCs) often show a dense infiltrate of cytokine-producing
immune/inflammatory cells. The exact contribution of each immune cell subset and cytokine …
immune/inflammatory cells. The exact contribution of each immune cell subset and cytokine …
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
BACKGROUND & AIMS: Cell-mediated immunity is a feature of Crohn's disease (CD). The
heterodimer interleukin (IL)-12, produced by phagocytes, induces T-cell cytokines, primarily …
heterodimer interleukin (IL)-12, produced by phagocytes, induces T-cell cytokines, primarily …
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract
BACKGROUND & AIMS: The pathogenesis of inflammatory bowel disease (IBD) is believed
to involve an altered balance between effector and regulatory T cells. Aryl hydrocarbon …
to involve an altered balance between effector and regulatory T cells. Aryl hydrocarbon …
[HTML][HTML] Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
G Monteleone, A Kumberova, NM Croft… - The Journal of …, 2001 - Am Soc Clin Investig
TGF-β1 functions as a negative regulator of T cell immune responses, signaling to target
cells using the Smad family of proteins. We show here that Smad7, an inhibitor of TGF-β1 …
cells using the Smad family of proteins. We show here that Smad7, an inhibitor of TGF-β1 …
[HTML][HTML] Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
G Monteleone, MF Neurath, S Ardizzone… - … England Journal of …, 2015 - Mass Medical Soc
Background Crohn's disease–related inflammation is characterized by reduced activity of
the immunosuppressive cytokine transforming growth factor β1 (TGF-β1) due to high levels …
the immunosuppressive cytokine transforming growth factor β1 (TGF-β1) due to high levels …
Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease
…, DS Rampton, GR Corazza, G Monteleone… - Gut, 2009 - gut.bmj.com
Background and Aims: Interleukin 17 (IL17) is now known to be involved in a number of
chronic inflammatory disorders. However, the mechanisms regulating its production in …
chronic inflammatory disorders. However, the mechanisms regulating its production in …